Search Within

Pang-Dian Fan

Formats
  1. Journal Article (10)
  2. Meeting Abstract (5)
Groups
  1. GSK Faculty (10)
  2. Department of Medicine (8)
  3. Department of Pathology and Laboratory Medicine (8)
  4. Human Oncology and Pathogenesis Program (8)
  5. Solid Tumor Oncology Division (8)
  6. Thoracic Oncology (8)

More Groups

People
  1. Marc Ladanyi (8)
  2. Harold Varmus (6)
  3. Helena Yu (6)
  4. Paul Paik (6)
  5. Achim Jungbluth (4)
  6. Gregory Riely (4)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2020 (2)
  4. 2018 (3)
  5. 2017 (2)
  6. 2015 (2)

More Years

Publications
  1. Journal of Clinical Oncology (3)
  2. Clinical Cancer Research (2)
  3. Journal of Thoracic Oncology (2)
  4. Cancer Discovery (1)
  5. Cancer Research (1)
  6. Disease Models & Mechanisms (1)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. American Society of Clinical Oncology (4)
  3. Elsevier Inc. (2)
  4. Academic Press Inc., Elsevier Science (1)
  5. Cold Spring Harbor Laboratory Press (1)
  6. Company of Biologists (1)

More Publishers

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting NFE2L2/KEAP1 mutations in advanced NSCLC with the TORC1/2 inhibitor TAK-228
    Journal Article

    Paik, P. K.; Fan, P. D.; Qeriqi, B.; Namakydoust, A.; Daly, B.; Ahn, L.; Kim, R.; Plodkowski, A.; Ni, A.; Chang, J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • SRC family kinase inhibition targets YES1 and YAP1 as primary drivers of lung cancer and as mediators of acquired resistance to ALK and epidermal growth factor receptor inhibitors
    Journal Article

    Sato, H.; Kubota, D.; Qiao, H.; Jungbluth, A.; Rekhtman, N.; Schoenfeld, A. J.; Yu, H. A.; Riely, G. J.; Toyooka, S.; Lovly, C. M.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • YES1 amplification as a primary driver of lung tumorigenesis and YES1/YAP1 amplifications as mediators of acquired resistance (AR) to ALK and EGFR tyrosine kinase inhibitors (TKIs)
    Meeting Abstract

    Sato, H.; Kubota, D.; Paik, P. K.; Qiao, H.; Jungbluth, A. A.; Rekhtman, N.; Schoenfeld, A. J.; Yu, H. A.; Riely, G. J.; Lovly, C. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase II study of TAK228 in patients with advanced non-small cell lung cancer (NSCLC) harboring NFE2L2 and KEAP1 mutations
    Meeting Abstract

    Paik, P. K.; Ahn, L. S. H.; Plodkowski, A. J.; Fan, P. D.; Rudin, C. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • ERBBal remedies: Combination therapy for EGFR-mutant lung cancers
    Journal Article

    Fan, P. D.; Yu, H. A.
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics
    Journal Article

    Fan, P. D.; Narzisi, G.; Jayaprakash, A. D.; Venturini, E.; Robine, N.; Smibert, P.; Germer, S.; Yu, H. A.; Jordan, E. J.; Paik, P. K.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2018)

    Fulltext@MSK | Save
  • Modeling of oncogenic chromosomal translocations of aggressive fusion-positive sarcomas by CRISPR-Cas9 genomic engineering
    Meeting Abstract

    Spraggon, L.; Martelotto, L.; Hmeljak, J.; Hitchman, T.; Wang, J.; Wang, L.; Slotkin, E.; Fan, P. D.; Reis-Filho, J.; Ladanyi, M.
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • YES1 amplification as a mechanism of acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKIs) identified by a transposon mutagenesis screen and clinical genomic testing
    Meeting Abstract

    Fan, P. D.; Narzisi, G.; Jayaprakash, A.; Venturini, E.; Robine, N.; Smibert, P.; Germer, S.; Jordan, E.; Wang, L.; Jungbluth, A. A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Generation of conditional oncogenic chromosomal translocations using CRISPR–Cas9 genomic editing and homology-directed repair
    Journal Article

    Spraggon, L.; Martelotto, L. G.; Hmeljak, J.; Hitchman, T. D.; Wang, J.; Wang, L.; Slotkin, E. K.; Fan, P. D.; Reis-Filho, J. S.; Ladanyi, M.
    Journal of Pathology (2017)

    Fulltext@MSK | Save
  • Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring met mutations causing exon 14 skipping
    Journal Article

    Paik, P. K.; Drilon, A.; Fan, P. D.; Yu, H.; Rekhtman, N.; Ginsberg, M. S.; Borsu, L.; Schultz, N.; Berger, M. F.; Rudin, C. M.; more...
    Cancer Discovery (2015)

    Fulltext@MSK | Save